ChronLAW.com News for attorneys, lawyers, and insurance, banking, credit, finance, government, education and law related professionals, covering politics, business, medicine, crime, law enforcement and other legal topics.
As new variants of the SARS-CoV-2 virus emerge, it is imperative that novel, active therap...
Regdanvimab—A New Attack of the (Mono)Clones – Contagionlive.com
As new variants of the SARS-CoV-2 virus emerge, it is imperative that novel, active therapeutics are available for treatment or prevention. Regdanvimab (CT-P59) is a neutralizing antibody that was studied in a phase 2/3 trial (NCT04602000) in…